Zacks Research Issues Pessimistic Estimate for BMY Earnings
Bristol-Myers Squibb (NYSE:BMY – Free Report) – Stock analysts at Zacks Research dropped their Q1 2025 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Thursday, February 20th. Zacks Research analyst E. Bagri now forecasts that the biopharmaceutical company will post earnings of $1.55 per share for the quarter, […]
